A Comparison of in vivo Tumor-Homing Abilities of Placental-Derived and Bone Marrow-Derived Mesenchymal Stromal Cells in High-Risk Neuroblastoma.

Neuroblastoma is an aggressive cancer that primarily affects young children, and it remains one of the deadliest childhood malignancies. One promising idea for improving treatment is to use special cells called mesenchymal stromal cells (MSCs) as delivery vehicles — essentially tiny biological "trucks" that could carry cancer-fighting drugs directly to a tumor. This approach relies on a natural property of MSCs: they tend to seek out and travel toward tumors on their own, a behavior known as tumor homing. MSCs can be sourced from different parts of the body, and two common sources are bone marrow and placental tissue (collected after childbirth). Before MSCs can be used as a drug-delivery system, though, scientists need to know whether they actually reach the tumor reliably, and whether one source works better than the other. This study set out to answer that question. The researchers worked with mice that had neuroblastoma tumor cells implanted directly into an adrenal gland, mimicking how this cancer often develops in real patients. The mice were then given an injection of either placental-derived MSCs, bone marrow-derived MSCs, or a plain saline solution as a control. To track where the injected cells traveled inside the body, the MSCs were labeled so they could be tracked using specialized whole-body imaging, taken at multiple points after injection. Some mice were examined 72 hours after injection, and others after 7 days, with additional close-up imaging performed on the tumors and other organs after removal. The results were encouraging. Both types of MSCs successfully made their way to the tumor site. Imaging initially showed the injected cells spread throughout the abdomen, but over time, the tracking signal concentrated specifically in the area of the tumor, in the left side of the abdomen where the tumor had been implanted. Even a full week after injection, MSCs were still detectable within the tumor tissue, while no meaningful signal showed up in other organs, suggesting the cells weren't simply spreading throughout the body indiscriminately. A closer look at the tumor tissue under the microscope confirmed that both types of MSCs had indeed embedded themselves within the tumor.